Donation

Resource
December 10, 2015​Generous Donations Help Fund 2016 Brian D. Novis Research GrantsThe IMF…
February 10, 2015
Resource
This glossary defines commonly used myeloma-related terms.-As of April 19, 2021Accrual: The process of enrolling patients in a clinical trial (research study), or the number of patients already enrolled in a trial or anticipated to enroll in a
November 21, 2019
Blog post
As we move into the holiday season, we are all looking forward to time with family and friends to enjoy, celebrate, and relax after a tumultuous year. This year was extraordinarily busy for the IMF, but in 2019 there were great steps forward to improve outcomes for myeloma patients everywhere.…
December 18, 2019
Resource
November 3, 2016NCCN Endorses MRD Testing: What Does This Mean for Patients?The…
November 03, 2016
Blog post
As the Black Swan Research Initiative (BSRI-- the IMF's innovative approach to finding a cure for myeloma --moves forward since its official launch in March, more and more myeloma researchers are contributing to the framework that is necessary to reach the project's…
July 10, 2013
Blog post
The International Myeloma Foundation (IMF)Black Swan Research Initiative (BSRI) is moving into high gear in the new year. Building on remarkable progress made by the BSRI team during the last months of 2013,…
January 08, 2014
Page
 Black Swan Research Initiative TeamTeam Leaders …
September 11, 2018
Blog post
May 28, 2020Virtual ASCOThis weekend, researchers would have been descending on Chicago for the56th Annual Meeting of the American Society of Clinical Oncology (ASCO)to learn the latest about myeloma research…
May 28, 2020
Blog post
July 23, 2020On Tuesday, July 21, there were no deaths from COVID-19 in Lombardy, Italy, the European epicenter of the COVID-19 pandemic. Five months after the first death on February 22, there has been a dramatic turnaround in Lombardy, and day-to-day life is returning…
July 23, 2020
Blog post
researcher-lab-gloved-hand-cover.jpg'/>April 15, 2021Achieving a cure for myeloma is what every patient wants, and it is the ultimate goal of all myeloma researchers. In 2012 the IMF established theBlack Swan Research…
April 15, 2021
Blog post
October 15, 2020We know that myeloma patients are especially vulnerable in this time of the COVID-19 pandemic. But what has been largely overlooked is that older adults, who make up the largest percentage of myeloma patients, are psychologically highly resilient. (…
October 14, 2020
Blog post
At this time of year, I am normally on vacation. Because of the pandemic I, like so many others, have not had a vacation for over a year. So, I decided to take a simulated vacation and create a more joyous environment filled with tranquility, music and articles/books not about COVID-19. …
March 25, 2021
Blog post
Research Results Published '/>Research Results Published '/>research-results' />March 4, 2021On February 26, the Food and Drug Administration (FDA)…
March 04, 2021
Blog post
April 8, 2021ABECMAAswe have reported, it is really exciting that the first anti-BCMA CAR T cell-therapy for myeloma, Abecma, wasapproved by the U.S. Food & Drug Administration.…
April 08, 2021
Videos
Black Swan Research Initiative UpdateDr. Brian G.M. DurieIMF Patient & Family Seminar 2017Boca Raton, FL | March 17-18
April 12, 2017
Videos
Thinking Outside of the Box to Conquer Multiple Myeloma How the IMF’s Black Swan Research Initiative Is Changing the Way We Approach Multiple Myeloma. Six years ago, the original team, led by IMF Chairman Brian G.M. Durie, MD,…
February 11, 2019
Page
The IMF's Signature Project to Find a CureThe Black Swan Research Initiative (BSRI) was established following a scientific brainstorming meeting linked to the IMWG Summit held in Amsterdam in 2012. The meeting occurred in a remote boathouse to ensure…
September 11, 2018
Videos
Black Swan UpdateDr. Brian GM DurieIMF Patient & Family Seminar 2018Boca Raton, FL | March  16-17Other Topics:…
March 16, 2018
Videos
Black Swan UpdateDr. Brian G.M. DurieIMF Patient & Family Seminar 2019Boca Raton, FL | March  16-17Other Topics:Ask the Experts…
April 05, 2019
News Article
INTERNATIONAL MYELOMA FOUNDATION 14THANNUAL COMEDY CELEBRATION GOES VIRTUAL IN 2020, FEATURING “EVERYBODY LOVES RAYMOND” CAST REUNIONHOSTED BY RAY ROMANO ON OCTOBER 23 AT 9 PM EST …
October 21, 2020
Videos
The IMWG Developed Biobank Enhances Myeloma ResearchIn this episode, myeloma expert Dr. Brian G.M. Durie discusses the creation of a virtual tissue biobank through the International Myeloma Working Group.The BOTTOM LINE:This virtual biobank will enhance
July 27, 2021
Page
At some point in the care continuum, cancer clinical trials can be a treatment option for many patients. Clinical research in multiple myeloma has become a robust field with the National Cancer Institute (NCI) websitecancer.govlisting more than…
September 04, 2018
Page
Key Terms Associated with Clinical Trial PhasesThe following terms are often used in discussions of a clinical trial and its phases.Arm– One of the treatment groups of a randomized trial. The majority of randomized trials have two, but…
September 04, 2018
News Article
Here are photos from the 2017 Comedy Celebration!  Don't miss out next year and save the date!EXCLUSIVE LIVE PRE-SHOW EVENT from the 2017 Comedy Celebration:Co-hosted by Miss Black USA Daphne Lee and TV personality Alie Ward …
November 04, 2017
News Article
Los Angeles, CA, Dec. 4, 2019—The International Myeloma Foundation (IMF) announced today that four important research studies supported by the organization'sBlack Swan Research Initiative®(BSRI) to find a cure for multiple…
December 03, 2019
Page
Funding promising myeloma researchIn 1995, the IMF established the Brian D. Novis Research Grant program in memory of its co-founder. The grants are awarded annually to promote research into all areas of myeloma in an effort to improve patient outcomes. To date, the…
September 11, 2018
Page
Consolidation therapy is generally defined as treatment given for a short duration (i.e., 2 to 4 cycles), usually with the same regimen used for induction therapy, following high-dose therapy withautologous stem cell transplant (ASCT).The goal of consolidation therapy is…
September 04, 2018
Page
Maintenancetherapy refers to treatment given to patients after high-dose chemotherapy with autologous stem cell transplant (ASCT), whilecontinuoustherapy refers to treatment given to patients who do not go on to transplant after frontline therapy.While…
September 04, 2018
Page
Empliciti® (elotuzumab) is the first monoclonal antibody approved to treat multiple myeloma. It is given intravenously (into the vein, IV) and taken in combination with the medicines Revlimid® (lenalidomide) and dexamethasone, in people who have received 1 to 3 prior treatments for their disease…
September 11, 2018
Page
A quarterly publication of myeloma research from our medical editorsThe IMF’s quarterly journal features scientific and clinical news and stories about education and awareness programs, patient meetings, and advocacy activities. Available online and by mail.Do you want to…
September 04, 2018
Audio
Listen to Multiple Myeloma Patient Deidra Jones Share Her StoryDeidra Jones talks about her myeloma diagnosis, coping with both congestive heart failure and multiple myeloma, undergoing treatment with Velcade and a clinical trial with venetoclax, as well as becoming an IMF…
May 24, 2021
Page
IMF's MissionFounded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of…
September 11, 2018
Videos
Elena Zamagni, MDBologna University School of MedicineBologna, ItalyProspective Evaluation of 18F-FDG PET/CT As Predictor of Prognosis in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients:…
December 03, 2016
Page
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients…
September 04, 2018
Videos
Discussing the SWOG-1211 Study Presented at ASCO 2020 Myeloma Expert Dr. Saad Usmani Discusses the SWOG-1211 Study Presented at ASCO 2020 What is the purpose of this trial?This partially randomized phase I/II trial studies the side…
June 18, 2020
Page
Caregivers need care too.As a caregiver, it is easy to be overwhelmed by caring for a loved one. An important point to remember is that you, as a caregiver, are also a survivor because you, too, are surviving the challenges, responsibilities, and life-changing effects of this disease…
September 04, 2018
Page
Update: 7/28/21 - FDA alerts patients and health care professionals about clinical trial results showing an increased…
March 24, 2021

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.